Sangamo Therapeutics products

Sangamo’s proprietary zinc finger (ZF) platform uniquely confers a number of advantages and has broad therapeutic potential due to its versatility, specificity and clinical utility. Zinc finger technologies are composed of a DNA-binding domain, which binds with precision to any sequence of DNA, and various functional domains (such as nucleases and transcription factors) based on therapeutic need. Due to their compact size, ZF technologies are highly vector compatible. Partnering ZF technologies with delivery vectors allows for the creation of ZF-based genomic medicines.